Tirzepatide, a recently approved medication, is generating significant buzz in the scientific community as a viable treatment for both managing blood sugar and weight loss . This dual-action drug works by activating two distinct receptors, GLP-1 and GIP, leading to enhanced blood sugar levels and substantial weight reduction in testing. While early